Profile data is unavailable for this security.
About the company
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
- Revenue in BRL (TTM)8.66bn
- Net income in BRL70.40m
- Incorporated1961
- Employees7.08k
- LocationProfarma Distribuidora de Produtos Farmaceuticos SAAvenida Ayrton Senna2150,Bloco P - 3 andar, Barra da TijucaRIO DE JANEIRO 22.775-900BrazilBRA
- Phone+55 2 140090200
- Fax+55 2 124913906
- Websitehttps://www.profarma.com.br/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natural Health Trends Corp. | 224.71m | 2.91m | 387.10m | 138.00 | 132.62 | 1.82 | 103.37 | 1.72 | 0.0495 | 0.0495 | 3.84 | 3.61 | 0.5783 | 2.53 | -- | 318,289.80 | 0.7478 | -0.5398 | 1.02 | -0.7099 | 74.56 | 74.06 | 1.29 | -0.9571 | 3.00 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
| Balaxi Pharmaceuticals Ltd | 160.79m | -3.20m | 396.20m | 51.00 | -- | -- | -- | 2.46 | -5.30 | -5.30 | 255.76 | -- | -- | -- | -- | 51,400,510.00 | -- | 31.86 | -- | 46.07 | 42.45 | 32.28 | -1.99 | 15.43 | -- | -- | -- | -- | 20.42 | -- | -3.56 | -- | 314.83 | -- |
| 111 Inc - ADR | 10.55bn | -277.24m | 442.16m | 1.66k | -- | -- | -- | 0.0419 | -0.6405 | -0.6405 | 24.47 | -0.9586 | 4.56 | 9.66 | 29.15 | -- | -10.77 | -17.09 | -- | -178.25 | 5.68 | 5.36 | -2.36 | -4.37 | 0.5457 | -32.73 | 0.5781 | -- | 10.59 | 52.95 | 5.80 | -- | -- | -- |
| Pharmaniaga Berhad | 3.65bn | -83.11m | 525.83m | 3.78k | -- | -- | -- | 0.1439 | -0.0572 | -0.0572 | 2.55 | -0.2056 | 1.82 | 4.59 | 9.57 | -- | -4.06 | -6.88 | -- | -38.45 | 9.04 | 6.64 | -2.23 | -3.66 | 0.2762 | 1.37 | 1.29 | -- | -3.02 | 7.38 | 87.25 | -- | 23.35 | -- |
| Sopharma Trading AD | 4.70bn | 83.99m | 541.67m | 2.62k | 6.45 | 1.56 | 3.12 | 0.1152 | 0.8761 | 0.8761 | 49.05 | 3.62 | 2.77 | 0.1598 | 7.91 | 642,617.00 | 4.95 | 2.43 | 14.93 | 7.97 | 98.03 | 98.08 | 1.79 | 1.02 | 0.6065 | 187.70 | 0.6132 | -- | 13.02 | 13.26 | 230.70 | 28.57 | 3.70 | -- |
| EQL Pharma AB | 115.39m | 10.37m | 589.39m | 19.00 | 58.51 | 7.27 | -- | 5.11 | 0.74 | 0.74 | 8.21 | 5.95 | 0.8025 | 1.79 | 3.56 | 13,687,060.00 | 7.21 | 8.77 | 11.96 | 14.23 | 45.33 | 39.60 | 8.98 | 7.63 | 0.5617 | 13.71 | 0.3616 | -- | -36.57 | -- | -1.99 | -- | -- | -- |
| Profarma Distribuidora de Produts Frm SA | 8.66bn | 70.40m | 727.79m | 7.08k | 10.33 | 0.5824 | 3.21 | 0.084 | 0.5742 | 0.5742 | 70.64 | 10.18 | 1.86 | 5.33 | 7.77 | -- | 1.67 | 1.64 | 3.63 | 3.40 | 14.92 | 14.61 | 0.8989 | 0.9519 | 0.8223 | 1.81 | 0.4263 | -- | 10.82 | 15.19 | -12.95 | -- | 41.08 | -- |
| Hemas Holdings PLC | 2.12bn | 96.65m | 892.11m | 5.38k | 9.24 | 1.26 | 6.68 | 0.4217 | 9.36 | 9.36 | 204.88 | 68.56 | 1.28 | 3.13 | 4.20 | 22,747,760.00 | 6.28 | 5.53 | 12.69 | 9.99 | 29.62 | 29.98 | 4.93 | 4.99 | 0.9711 | 3.28 | 0.3388 | 41.15 | 44.54 | 17.51 | 0.4779 | 9.70 | -9.33 | 5.66 |
| Charmacy Pharmaceutical Co Ltd | 3.11bn | 36.28m | 983.86m | 831.00 | 27.12 | 2.33 | 36.42 | 0.3162 | 0.514 | 0.514 | 44.09 | 5.99 | 1.44 | 6.05 | 4.88 | 5,729,909.00 | 1.68 | 1.79 | 8.28 | 7.99 | 6.35 | 6.11 | 1.17 | 1.24 | 0.7775 | 2.71 | 0.5111 | 37.10 | 5.47 | 2.27 | -43.25 | 2.48 | -- | 0.0193 |
Data as of Apr 27 2024. Currency figures normalised to Profarma Distribuidora de Produtos Farmaceuticos SA's reporting currency: Brazilian Real BRL
17.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lis Capital Adm. e Gestora De Recursos Financeiros Ltdaas of 25 Jul 2023 | 12.35m | 9.98% |
| Conc�rdia Gest�o de Recursos Ltda.as of 31 Dec 2023 | 8.22m | 6.64% |
| River Global Investors LLPas of 31 Mar 2024 | 577.27k | 0.47% |
| BTG Pactual WM Gest�o de Recursos Ltda.as of 31 Dec 2023 | 515.00k | 0.42% |
| XP Advisory Gest�o Recursos Ltda.as of 31 Dec 2023 | 200.00k | 0.16% |
| Bigu� Capital Gest�o de Recursos Ltda.as of 30 Apr 2023 | 118.40k | 0.10% |
| Alfa Previd�ncia e Vida SAas of 31 Dec 2023 | 100.00k | 0.08% |
| Schroder Investment Management Brasil Ltda.as of 31 Dec 2023 | 53.18k | 0.04% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 27.40k | 0.02% |
| Lazard Asset Management LLCas of 31 Mar 2024 | 26.30k | 0.02% |
More ▼
Data from 30 Apr 2023 - 25 Apr 2024Source: FactSet Research Systems Inc.
